Toremifene in Treating Patients With Desmoid Tumors
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Estrogen can stimulate the growth of cancer cells. Hormone therapy using
toremifene may fight the growth of desmoid tumors by reducing the production of estrogen.
PURPOSE: Phase II trial to study the effectiveness of toremifene in treating patients with
desmoid tumors.
Phase:
Phase 2
Details
Lead Sponsor:
Advocate Lutheran General Hospital Lutheran General Hospital